Related Experiment Video
Updated: Jun 17, 2026

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
Published on: January 7, 2019
Differentiation of multiple system atrophy subtypes by gray matter atrophy
Anna Campabadal1,2, Alexandra Abos1, Barbara Segura1,2,3
1Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
Background And Purpose:
Multiple system atrophy(MSA) is a rare adult-onset synucleinopathy that can be divided in two subtypes depending on whether the prevalence of its symptoms is more parkinsonian or cerebellar (MSA-P and MSA-C, respectively). The aim of this work is to investigate the structural MRI changes able to discriminate MSA phenotypes.
Methods:
The sample includes 31 MSA patients (15 MSA-C and 16 MSA-P) and 39 healthy controls. Participants underwent a comprehensive motor and neuropsychological battery. MRI data were acquired with a 3T scanner (MAGNETOM Trio, Siemens, Germany). FreeSurfer was used to obtain volumetric and cortical thickness measures. A Support Vector Machine (SVM) algorithm was used to assess the classification between patients' group using cortical and subcortical structural data.
Results:
After correction for multiple comparisons, MSA-C patients had greater atrophy than MSA-P in the left cerebellum, whereas MSA-P showed reduced volume bilaterally in the pallidum and putamen. Using deep gray matter volume ratios and mean cortical thickness as features, the SVM algorithm provided a consistent classification between MSA-C and MSA-P patients (balanced accuracy 74.2%, specificity 75.0%, and sensitivity 73.3%). The cerebellum, putamen, thalamus, ventral diencephalon, pallidum, and caudate were the most contributing features to the classification decision (z > 3.28; p < .05 [false discovery rate]).
Conclusions:
MSA-C and MSA-P with similar disease severity and duration have a differential distribution of gray matter atrophy. Although cerebellar atrophy is a clear differentiator between groups, thalamic and basal ganglia structures are also relevant contributors to distinguishing MSA subtypes.
Insights
Structural MRI reveals distinct patterns of brain atrophy in Multiple System Atrophy subtypes. Cerebellar and basal ganglia changes help differentiate between cerebellar (MSA-C) and parkinsonian (MSA-P) phenotypes.
Area of Science:
- Neuroimaging
- Neurology
- Radiology
Background:
- Multiple system atrophy (MSA) is a rare adult-onset synucleinopathy.
- MSA presents with two main subtypes: MSA-P (predominantly parkinsonian symptoms) and MSA-C (predominantly cerebellar symptoms).
- Distinguishing between MSA subtypes is crucial for understanding disease progression and potential targeted treatments.
Purpose of the Study:
- To investigate structural Magnetic Resonance Imaging (MRI) changes that can differentiate between MSA-P and MSA-C phenotypes.
- To identify specific brain regions and their volumetric/thickness alterations associated with each MSA subtype.
Main Methods:
- Utilized MRI data from 31 MSA patients (15 MSA-C, 16 MSA-P) and 39 healthy controls.
- Employed FreeSurfer for volumetric and cortical thickness measurements.
- Applied a Support Vector Machine (SVM) algorithm for classification between MSA subtypes using structural MRI data.
Main Results:
- MSA-C patients exhibited greater atrophy in the left cerebellum compared to MSA-P patients.
- MSA-P patients showed reduced volume in the bilateral pallidum and putamen.
- The SVM model achieved a balanced accuracy of 74.2% in classifying MSA subtypes, with key features including cerebellum, putamen, thalamus, and pallidum.
Conclusions:
- Differential gray matter atrophy patterns exist between MSA-C and MSA-P, even with similar disease severity and duration.
- Cerebellar atrophy is a significant differentiator, alongside contributions from thalamic and basal ganglia structures.
- Structural MRI analysis, particularly using SVM, can effectively distinguish between MSA subtypes.
Related Concept Videos
Multiple Sclerosis l: Introduction
Alzheimer Disease ll: Pathophysiology
Dementia l: Introduction

